Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Sees Large Growth in Short Interest

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 2,800 shares, an increase of 300.0% from the October 31st total of 700 shares. Based on an average daily volume of 3,500 shares, the short-interest ratio is presently 0.8 days.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Up 0.2 %

Shares of HROWL stock traded up $0.04 on Friday, hitting $25.39. 1,792 shares of the stock traded hands, compared to its average volume of 5,463. The firm has a 50 day simple moving average of $25.41 and a two-hundred day simple moving average of $25.28. Harrow Health, Inc. 8.625% Senior Notes due 2026 has a 52 week low of $23.65 and a 52 week high of $25.73.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th were paid a $0.5391 dividend. The ex-dividend date was Tuesday, October 15th. This represents a $2.16 dividend on an annualized basis and a yield of 8.49%.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.